- List
- By Topic
- On Map
- Search Details
Study record managers: refer to the Data Element Definitions if submitting registration or results information.
x
1 | NCT00783367 | Active, not recruiting | Combination Therapy Using Lenalidomide (Revlimid)- Low Dose Dexamethasone and Rituximab for Treatment of Rituximab-Resistant, Non-Aggressive B-Cell Lymphomas |
|
|
Interventional | Phase 2 |
|
Other |
|
|
25 | All | 18 Years and older (Adult, Senior) | NCT00783367 | UPCC 02408 UPenn IRB#807684 RV-NHL-PI-0296 |
July 2008 | December 2013 | October 31, 2008 | January 25, 2017 |
|